loadpatents
Patent applications and USPTO patent grants for Levine; Bruce L..The latest application filed is for "methods for improving the efficacy and expansion of immune cells".
Patent | Date |
---|---|
Toxicity management for anti-tumor activity of CARs Grant 11,273,219 - June , et al. March 15, 2 | 2022-03-15 |
Methods For Improving The Efficacy And Expansion Of Immune Cells App 20210246423 - Bedoya; Felipe ;   et al. | 2021-08-12 |
ICOS critically regulates the expansion and function of inflammatory human Th17 cells Grant 11,001,805 - Riley , et al. May 11, 2 | 2021-05-11 |
Methods for improving the efficacy and expansion of immune cells Grant 10,829,735 - Bedoya , et al. November 10, 2 | 2020-11-10 |
Toxicity management for anti-tumor activity of CARs Grant 10,603,378 - June , et al. | 2020-03-31 |
Compositions and Methods for Regulating CAR T Cells App 20190367610 - June; Carl H. ;   et al. | 2019-12-05 |
Methods For Treating Chronic Lymphocytic Leukemia (cll) App 20190336530 - June; Carl H. ;   et al. | 2019-11-07 |
Methods Of Making Chimeric Antigen Receptor - Expressing Cells App 20190292257 - Bedoya; Felipe ;   et al. | 2019-09-26 |
Methods of making chimeric antigen receptor-expressing cells Grant 10,273,300 - Bedoya , et al. | 2019-04-30 |
ICOS Critically Regulates the Expansion and Function of Inflammatory Human Th17 Cells App 20180371414 - Riley; James L. ;   et al. | 2018-12-27 |
Use Of Cart19 To Deplete Normal B Cells To Induce Tolerance App 20180271907 - June; Carl H. ;   et al. | 2018-09-27 |
Compositions and Methods for Treatment of Cancer App 20180258391 - June; Carl H. ;   et al. | 2018-09-13 |
Toxicity Management for Anti-Tumor Activity of CARs App 20180256712 - June; Carl H. ;   et al. | 2018-09-13 |
Toxicity Management for Anti-Tumor Activity of CARs App 20180243411 - June; Carl H. ;   et al. | 2018-08-30 |
Methods for treating chronic lymphocytic leukemia (CLL) Grant 10,046,008 - June , et al. August 14, 2 | 2018-08-14 |
ICOS critically regulates the expansion and function of inflammatory human Th17 cells Grant 9,994,818 - Riley , et al. June 12, 2 | 2018-06-12 |
Methods For Improving The Efficacy And Expansion Of Chimeric Antigen Receptor?expressing Cells App 20180133296 - Barrett; David Maxwell ;   et al. | 2018-05-17 |
Compositions and Methods for Treatment of Cancer App 20170283775 - June; Carl H. ;   et al. | 2017-10-05 |
Methods For Improving The Efficacy And Expansion Of Immune Cells App 20170137783 - Bedoya; Felipe ;   et al. | 2017-05-18 |
Methods for assessing the suitability of transduced T cells for administration Grant 9,572,836 - June , et al. February 21, 2 | 2017-02-21 |
Compositions and methods for treatment of cancer Grant 9,540,445 - June , et al. January 10, 2 | 2017-01-10 |
Compositions and methods for treatment of cancer Grant 9,518,123 - June , et al. December 13, 2 | 2016-12-13 |
Use of chimeric antigen receptor-modified T-cells to treat cancer Grant 9,499,629 - June , et al. November 22, 2 | 2016-11-22 |
Compositions and methods for treatment of cancer Grant 9,481,728 - June , et al. November 1, 2 | 2016-11-01 |
Compositions and methods for treatment of cancer Grant 9,464,140 - June , et al. October 11, 2 | 2016-10-11 |
Epitope Spreading Associated with CAR T-Cells App 20160235787 - June; Carl H. ;   et al. | 2016-08-18 |
Compositions and Methods for Treatment of Cancer App 20160208012 - June; Carl H. ;   et al. | 2016-07-21 |
Compositions and Methods for Treatment of Cancer App 20160194404 - June; Carl H. ;   et al. | 2016-07-07 |
Methods Of Making Chimeric Antigen Receptor -expressing Cells App 20160185861 - Bedoya; Felipe ;   et al. | 2016-06-30 |
Compositions and Methods for Treatment of Cancer App 20160159907 - June; Carl H. ;   et al. | 2016-06-09 |
Compositions and Methods for Treatment of Cancer App 20160130355 - June; Carl H. ;   et al. | 2016-05-12 |
Use of chimeric antigen receptor-modified T cells to treat cancer Grant 9,328,156 - June , et al. May 3, 2 | 2016-05-03 |
Methods For Treating Chronic Lymphocytic Leukemia (cll) App 20160000829 - June; Carl H. ;   et al. | 2016-01-07 |
ICOS Critically Regulates the Expansion and Function of Inflammatory Human Th17 Cells App 20150342994 - Riley; James L. ;   et al. | 2015-12-03 |
Use Of Cart19 To Deplete Normal B Cells To Induce Tolerance App 20150290244 - June; Carl H. ;   et al. | 2015-10-15 |
Compositions for treatment of cancer Grant 9,102,761 - June , et al. August 11, 2 | 2015-08-11 |
Compositions for treatment of cancer Grant 9,102,760 - June , et al. August 11, 2 | 2015-08-11 |
Methods for treatment of cancer Grant 9,101,584 - June , et al. August 11, 2 | 2015-08-11 |
Toxicity Management for Anti-Tumor Activity of CARs App 20150202286 - June; Carl H. ;   et al. | 2015-07-23 |
Methods for Assessing the Suitability of Transduced T Cells for Administration App 20150190428 - June; Carl H. ;   et al. | 2015-07-09 |
Compositions and Methods for Regulating CAR T Cells App 20150140019 - June; Carl H. ;   et al. | 2015-05-21 |
Methods for Treatment of Cancer App 20150118202 - June; Carl H. ;   et al. | 2015-04-30 |
Compositions for Treatment of Cancer App 20150099299 - June; Carl H. ;   et al. | 2015-04-09 |
Compositions for Treatment of Cancer App 20150093822 - June; Carl H. ;   et al. | 2015-04-02 |
Compositions for treatment of cancer Grant 8,975,071 - June , et al. March 10, 2 | 2015-03-10 |
Compositions for Treatment of Cancer App 20150050729 - June; Carl H. ;   et al. | 2015-02-19 |
Methods for treatment of cancer Grant 8,916,381 - June , et al. December 23, 2 | 2014-12-23 |
Methods for Treatment of Cancer App 20140370017 - June; Carl H. ;   et al. | 2014-12-18 |
Compositions for treatment of cancer Grant 8,911,993 - June , et al. December 16, 2 | 2014-12-16 |
Methods for treatment of cancer Grant 8,906,682 - June , et al. December 9, 2 | 2014-12-09 |
Use of Chimeric Antigen Receptor-Modified T Cells to Treat Cancer App 20140106449 - June; Carl H. ;   et al. | 2014-04-17 |
Methods for Treatment of Cancer App 20130309258 - June; Carl H. ;   et al. | 2013-11-21 |
Use of Chimeric Antigen Receptor-Modified T-Cells to Treat Cancer App 20130287748 - June; Carl H. ;   et al. | 2013-10-31 |
Compositions for Treatment of Cancer App 20130288368 - June; Carl H. ;   et al. | 2013-10-31 |
Methods for downregulating CCR5 in T cells with anti-CD3 antibodies and anti-CD28 antibodies Grant 7,927,595 - June , et al. April 19, 2 | 2011-04-19 |
Methods for modulating expression of an HIV-1 fusion cofactor App 20060204500 - June; Carl H. ;   et al. | 2006-09-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.